Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal

BSE3261.60-50.4 (-1.52 %)

PREV CLOSE ( ) 3312.00

OPEN PRICE ( ) 3305.45

BID PRICE (QTY) 3258.00 (1)

OFFER PRICE (QTY) 3261.35 (4)

VOLUME 3735

TODAY'S LOW / HIGH ( )3256.25 3345.10

52 WK LOW / HIGH ( )2295.1 3645

NSE3274.20-34.7 (-1.05 %)

PREV CLOSE( ) 3308.90

OPEN PRICE ( ) 3308.80

BID PRICE (QTY) 3274.20 (2)

OFFER PRICE (QTY) 3275.00 (5)

VOLUME 41269

TODAY'S LOW / HIGH( ) 3263.00 3345.00

52 WK LOW / HIGH ( )2293.55 3653.95

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

6698

6026

5967

6602

Total Expenditure

4775

4336

4427

4577

PBIDT (Excl OI)

1923

1690

1540

2025

Other Income

281

258

251

219

Operating Profit

2204

1948

1791

2244

Interest

Exceptional Items

PBDT

2157

1898

1738

2184

Depreciation

346

364

355

353

Profit Before Tax

1811

1534

1383

1831

Tax

471

-21

402

523

Provisions and contingencies

Profit After Tax

1340

1555

981

1308

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1340

1555

981

1308

Minority Interest

-16

-7

-14

-16

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1324

1548

967

1292

Equity Capital

838

836

Face Value (IN RS)

Reserves

Calculated EPS

15.79

18.51

11.56

15.45

Calculated EPS (Annualised)

63.19

74.06

46.26

61.81

No of Public Share Holdings

38714375

38530600

38526600

38513117

% of Public Share Holdings

46.21

46.09

46.08

PBIDTM% (Excl OI)

28.71

28.04

25.80

30.67

PBIDTM%

32.90

32.32

30.01

33.98

PBDTM%

32.20

31.49

29.12

33.08

PBTM%

27.03

25.45

23.17

27.73

PATM%

20.00

25.80

16.44

19.81

Notes

Risk Disclosures on Derivatives

Quarterly Results

DR. LAL PATHLABS LTD.